INOVIO PHARMACEUTICALS, INC. (INO) › Operating Cash FlowINOVIO PHARMACEUTICALS, INC. (INO) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$14.08M2010: -$11.94M2011: -$19.76M2012: -$22.31M2013: -$15.38M2014: -$29.82M2015: -$12.44M2016: -$62.56M2017: -$63.21M2018: -$73.55M2019: -$97.85M2020: -$177.98M2021: -$215.71M2022: -$216.22M2023: -$124.37M2024: -$104.08M2025: -$88.63M-$88.63M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$88.63M+14.8%2024-$104.08M+16.3%2023-$124.37M+42.5%2022-$216.22M-0.2%2021-$215.71M-21.2%2020-$177.98M-81.9%2019-$97.85M-33.0%2018-$73.55M-16.4%2017-$63.21M-1.0%2016-$62.56M-402.9%2015-$12.44M+58.3%2014-$29.82M-93.9%2013-$15.38M+31.0%2012-$22.31M-12.9%2011-$19.76M-65.5%2010-$11.94M+15.2%2009-$14.08M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share